In focus · trending topic

RNA editing

10 stories · following the connections

ProQR Announces Conference Presentations for Axiomer® RNA Editing Technology and QR-313 for DEB

By Nasdaq OMXApr 30, 2018, 11:00 AM UTC

ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology

By Nasdaq OMXApr 10, 2018, 11:00 AM UTC

ProQR to Present at Upcoming Scientific Meeting and Investor Conference

By Nasdaq OMXFeb 6, 2018, 12:00 PM UTC

ProQR to Present at the Annual Piper Jaffray Healthcare Conference

By Nasdaq OMXNov 21, 2017, 12:00 PM UTC

ProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic Blindness

By Nasdaq OMXNov 13, 2017, 12:00 PM UTC

ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board

By Nasdaq OMXNov 9, 2017, 12:01 PM UTC

ProQR to Present at EuroTIDES Conference

By Nasdaq OMXOct 31, 2017, 11:00 AM UTC

ProQR Announces Presentations and Investor & Analyst Event at the North American Cystic Fibrosis Conference

By Nasdaq OMXOct 24, 2017, 11:00 AM UTC